INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 41h ago
HOUSE PTR1h ago
SEC 13F1h ago
ROBINHOOD CHAIN1h ago
SEC FORM 4/Grant or awardVerified data

Peterson Robert Charles reported BTMD

Chief Financial Officer · biote Corp. · biote Corp. — Employee Stock Option (Right to Buy)

Side
A
Value
—
Shares
107.2K
Price
—
Executed
Apr 1, 2026
Disclosed
Apr 3, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Apr 1 executedApr 3, 2026 disclosed

BTMD · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
9/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Grant or award — administrative, little informational value

  • Relative size+1 / 25

No reported dollar value · new position

  • Filing timing0 / 15

    Disclosed 2 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · BTMD

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    9
    PC
    Peterson Robert CharlesDirector, Interim CEO
    BTMDbiote Corp.
    Grant or award
    		A—
    206.7K sh
    		Jun 12, 2026Jun 16, 2026
    traded Jun 12, 2026
    		+4dSEC FORM 4

    Evidence

    21
    CM
    Cone Stephen MarkDirector
    BTMDbiote Corp.
    Grant or award
    		A—
    31.5K sh
    		May 12, 2026May 13, 2026
    traded May 12, 2026
    		+1dSEC FORM 4

    Evidence

    9
    CM
    Cone Stephen MarkDirector
    BTMDbiote Corp.
    Grant or award
    		A—
    130.0K sh
    		May 12, 2026May 13, 2026
    traded May 12, 2026
    		+1dSEC FORM 4

    Evidence

    21
    JL
    Jacoby Dana LynnDirector
    BTMDbiote Corp.
    Grant or award
    		A—
    37.8K sh
    		May 12, 2026May 13, 2026
    traded May 12, 2026
    		+1dSEC FORM 4

    Evidence

    9
    JL
    Jacoby Dana LynnDirector
    BTMDbiote Corp.
    Grant or award
    		A—
    130.0K sh
    		May 12, 2026May 13, 2026
    traded May 12, 2026
    		+1dSEC FORM 4

    Evidence

    9
    MM
    Monico Daniel MichaelGeneral Counsel
    BTMDbiote Corp.
    Grant or award
    		A—
    88.8K sh
    		May 1, 2026May 4, 2026
    traded May 1, 2026
    		+3dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0002005188-26-000002
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Apr 1, 2026
    Published
    Apr 3, 2026
    Ingested by INSIDER
    Nov 5, 04:07 UTC
    Last re-read
    Nov 5, 04:07 UTC

    Extracted facts

    Filer
    Peterson Robert Charles
    Role
    Chief Financial Officer
    Transaction
    Grant or awardAs filed: “A”
    Asset
    biote Corp. — Employee Stock Option (Right to Buy)
    Ticker
    BTMD
    Shares
    107.2K
    Price per share
    $0
    Execution date (reported)
    Apr 1, 2026
    Owned after transaction
    107.2K shares
    Days from execution to publication
    2

    What this establishes

    Peterson Robert Charles filed this Form 4 reporting a grant or award of BTMD on Apr 1, 2026. It became public on Apr 3, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Chief Financial Officer
    Peterson Robert Charlescik:0002005188
    Issuer
    biote Corp.cik:0001819253

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.